AKER BIOMARINE |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73 NOK | -1.08% |
|
0.00% | +58.70% |
| Apr. 26 | Aker BioMarine AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 26 | Transcript : Aker BioMarine AS, Q1 2024 Earnings Call, Apr 26, 2024 |
Evolution of the average Target Price on Aker BioMarine
Price target over the last 5 years
History of analyst recommendation changes
ca3ade7c3488c26d9b0f9e0bfd78.e9FI8fGaZwAET_trCPWkxvjO0zC1lgDPa2w-jdmHvsU.KJsquavPM3FbKY1fS6PFqKibqUf82VOQJlxR557g8vAKqyOgptJWQ2ktnA~abd149784198d48510eaa63e7d34c05e
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
6.821
USD
Average target price
6.641
USD
Spread / Average Target
-2.64%
High Price Target
6.915
USD
Spread / Highest target
+1.38%
Low Price Target
6.367
USD
Spread / Lowest Target
-6.66%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B-
EPS Revisions
- Stock Market
- Equities
- AKBM Stock
- Consensus Aker BioMarine